Health officials in Denmark and Norway said Thursday they have temporarily suspended the use of AstraZeneca’s COVID-19 vaccines after reports of the formation of blood clots in some who have been vaccinated

The move came after Austria stopped using a number of AstraZeneca shots while investigating death from coagulation disorders and disease due to pulmonary embolism

Danish health officials said the country’s decision to suspend the shots for two weeks was made after a 60-year-old woman in Denmark who received an AstraZeneca shot from the same batch that was used in Austria, a Had formed a blood clot and died

The Danish authorities said they had responded to reports of possible serious side effects from both Denmark and other European countries ”

“It is currently not possible to determine whether there is a link. We are acting early, it has to be investigated thoroughly,” said Health Minister Magnus Heunicke on Twitter

“This is a cautious decision,” said Geir Bukholm, Director of Infection Prevention and Control at the Norwegian Institute for Public Health (FHI), at a press conference

“We … are waiting for information to see if there is any connection between the vaccination and this case with a blood clot,” said Bukholm

Also on Thursday, Italy announced that it would suspend the use of an AstraZeneca batch different from the one used in Austria

Some health professionals said there was little evidence that the AstraZeneca vaccine should not be given and that the incidence of blood clots was consistent with the rate of such cases in the general population

“This is an extremely cautious approach based on some isolated reports in Europe,” Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, told Reuters

“The problem with spontaneous reports of suspected vaccine side effects is the tremendous difficulty in distinguishing a causal effect from a coincidence,” he said, adding that COVID-19 disease is very closely related to blood clotting / p>

AstraZeneca told Reuters in a written statement Thursday that the safety of its vaccine had been extensively studied in human studies and peer-reviewed data had confirmed that the vaccine was generally well tolerated

The drug manufacturer said earlier this week that its recordings had undergone rigorous quality controls and that “there were no confirmed serious adverse events related to the vaccine, it said it was in contact with the Austrian authorities and would fully support their investigations” / p>
The European Union Medicines Agency, the European Medicines Agency (EMA), endorsed the use of AstraZeneca’s COVID-19 vaccine, saying its benefits outweigh the risks

The Medicines Agency said on Wednesday that there is no evidence yet that could link AstraZeneca to the two cases in Austria

It is said that the number of thromboembolic events – characterized by the formation of blood clots – is no higher in people who received the AstraZeneca vaccine than in the general population 22 cases of such events were reported among the 3 million people who saw it as of April 9 March received

Four other countries – Estonia, Lithuania, Luxembourg and Latvia – have suspended vaccinations from the batch while investigations continue, the EMA


Continue reading:
The AstraZeneca coronavirus vaccine arrives in Manitoba and launches in pharmacies, clinics, and pop-up sites

The Swedish authorities said they did not find sufficient evidence to stop vaccination with AstraZeneca’s vaccine Sweden has two cases of “thromboembolic events” related to AstraZeneca’s vaccine and about ten cases for Pfizer-BioNTech -Vaccine detected

“We see no reason to revise our recommendation,” said Veronica Arthurson, director of drug safety at the Swedish Medical Products Agency, at a press conference. “There is nothing to suggest that the vaccine causes these types of blood clots”

Spain announced on Thursday that it has not yet registered any cases of blood clots related to AstraZeneca’s vaccine and will continue to administer the shots

Get a recap of the most important and intriguing national stories delivered to your inbox every weekday

Get a recap of the most important and intriguing national stories delivered to your inbox every weekday

AstraZeneca vaccine, AstraZeneca

World News – CA – Denmark, Norway, Italy temporarily suspend use of AstraZeneca vaccine